Bayesian Capital Management »

Cerevel Therapeutics Hldng I shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 43k 42.40
2023-09-30 $631k 29k 21.83

More positions owned by Bayesian Capital Management

Qualcomm (QCOM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads (BABA)
Microsoft Corporation (MSFT)
Micron Technology (MU)
CVS Caremark Corporation (CVS)
salesforce (CRM)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Datadog Cl A Com (DDOG)
International Flavors & Fragrances (IFF)
Target Corporation (TGT)
Exxon Mobil Corporation (XOM)
Intuitive Surgical Com New (ISRG)
Procter & Gamble Company (PG)

View all positions for Bayesian Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I